|
[1]National Health and Family Planning Commission of the People's Republic of China.Diagnosis, management, and treatment of hepatocellular carcinoma (V2017) [J].J Clin Hepatol, 2017, 33 (8) :1419-1431. (in Chinese) 中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范 (2017年版) [J].临床肝胆病杂志, 2017, 33 (8) :1419-1431.
|
|
[2]GUO TZ, HAN LX, LUO Y, et al.Risk factors of liver cancer in patients with hepatitis B virus infection[J].Int J Virol, 2016, 23 (1) :26-28. (in Chinese) 郭铁志, 韩立新, 罗研, 等.乙型肝炎病毒感染患者肝癌发病的影响因素研究[J].国际病毒学杂志, 2016, 23 (1) :26-28.
|
|
[3]CHEN CH, HUANG GT, YANG PM, et al.Hepatitis B-and C-related hepatocellular carcinomas yield different clinical features and prognosis[J].Eur J Cancer, 2006, 42 (15) :2524-2529.
|
|
[4]LIU FB, GENG XP.Choice of surgical treatment of large hepatocellular carcinoma[J].J Hepatobiliary Surg, 2017, 25 (1) :1-4. (in Chinese) 刘付宝, 耿小平.巨大肝癌外科手术治疗的抉择[J].肝胆外科杂志, 2017, 25 (1) :1-4.
|
|
[5]Ministry of Health of the People's Republic of China.Diagnosis, management, and treatment of hepatocellular carcinoma (V2011) [J].J Clin Hepatol, 2011, 27 (11) :1141-1159. (in Chinese) 中华人民共和国卫生部.原发性肝癌诊疗规范 (2011年版) [J].临床肝胆病杂志, 2011, 27 (11) :1141-1159.
|
|
[6]ZHENG JS, LONG J, SUN B, et al.Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis:Extending the indication for ablation?[J].Clin Radiol, 2014, 69 (6) :e253-e263.
|
|
[7]LI Z, ZHU JY.An interpretation of diagnosis, management, and treatment of hepatocellular carcinoma (V2017) [J].J Clin Hepatol, 2017, 33 (9) :1655-1657. (in Chinese) 李照, 朱继业.《原发性肝癌诊疗规范 (2017年版) 》解读[J].临床肝胆病杂志, 2017, 33 (9) :1655-1657.
|
|
[8]National Comprehensive Cancer Network.The NCCN Clinical Practice Guidelines in Oncology (version 3.2017) [EB/OL].[2017-08-15].www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf
|
|
[9]ZHU SL, ZHONG JH, KE Y, et al.Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma[J].World J Gastroenterol, 2015, 21 (32) :9630-9637.
|
|
[10]GAO F, GU YK, FAN WJ, et al.Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma[J].World J Gastroenterol, 2011, 17 (26) :3145-3150.
|
|
[11]SHRAGER B, JIBARA GA, TABRIZIAN P, et al.Resection of large hepatocellular carcinoma (≥10 cm) :A unique western perspective[J].J Surg Oncol, 2013, 107 (2) :111-117.
|
|
[12]KIM KH, KIM MS, CHANG JS, et al.Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma[J].Liver Int, 2014, 34 (5) :784-794.
|
DownLoad: